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Abstract
Background: Carotid atherosclerosis should not be neglected as a cause for stroke in China, despite its low
prevalence. This study was performed to evaluate the association between ultrasonographic markers for dif-
ferent stages of carotid atherosclerosis and metabolic syndrome.
Methods: This was a community-based study in Hong Kong. Metabolic syndrome was defined as having three
or more of the following conditions or receiving specific treatment for these conditions: Abdominal obesity,
elevated triglycerides, low high-density lipoprotein cholesterol, hypertension, and impaired fasting blood glu-
cose. All subjects underwent carotid duplex ultrasonography. Mean carotid intima media thickness (CIMT) of
bilateral common carotid arteries was used as the CIMT value for a single subject. CIMT within the 4th quartile
was regarded as increased CIMT. Carotid plaque was defined as a focal CIMT of > 1.5mm. A carotid plaque
obstructing ‡ 50% of vessel lumen was considered as carotid stenosis.
Results: A total of 653 subjects (mean age 55.1 – 10.4; 47.2% male) were recruited. Metabolic syndrome was
found in 188 (28.8%) subjects (30.8% in males and 27.0% in females). Mean CIMT was 0.74 – 0.12mm. Increased
CIMT, carotid plaque, and carotid stenosis were detected in 163 (25.0%), 95 (14.5%), and 6 (1.4%) subjects,
respectively. In multivariate linear regression, CIMT significantly increased with increasing numbers of meta-
bolic syndrome components (P < 0.001). In multivariate logistic regression analysis, metabolic syndrome was
independently associated with increased CIMT [odds ratio (OR) 1.17; 95% confidence interval (CI) 1.11–2.64;
P = 0.014), but not presence of carotid plaque (OR 1.50; 95% CI 0.92–2.46; P= 0.108).
Conclusions: Metabolic syndrome may be independently associated with the early stage but not the later and
advanced stages of carotid atherosclerosis in community residents in China.
Introduction
There are racial differences in predilection of locationof cervicocerebral arterial atherosclerosis between Cau-
casians and Asians.1 Despite a relatively lower prevalence in
Asians than that in Caucasians, carotid atherosclerosis
should not be neglected in Asian populations as a cause for
ischemic stroke and transient ischemic attack, which has
been increasing during the recent years.2–6 Carotid intima
media thickness (CIMT), carotid plaque, and carotid stenosis
determined by noninvasive ultrasonographic assessment are
markers for carotid atherosclerosis and reflect different
stages and aspects of atherosclerosis of the carotid arteries.
Increased CIMT mainly represents diffuse hypertensive hy-
pertrophic response of smooth muscle cells, which is the
early stage of carotid atherosclerosis, whereas the presence of
carotid plaque and carotid stenosis reflects later and ad-
vanced stages of the atherosclerotic process.7–9
Metabolic syndrome,10 a cluster of metabolic factors that
includes abdominal obesity, elevated triglycerides (TG),
low high-density lipoprotein cholesterol (HDL-C), hyper-
tension, and impaired fasting blood glucose (FBG), has been
found to be a predictor for different stages of carotid ath-
erosclerosis in large studies in Caucasians.11–14 According
to a cross-sectional study (2000–2001) performed in 15,540
subjects aged 35–74 years, a large proportion of Chinese
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adults have metabolic syndrome, with a prevalence of
13.7% [95% confidence interval (CI), 12.9–14.5%].15 Meta-
bolic syndrome incidence is still increasing with changes of
lifestyles in China.
In the present study, we evaluated the association be-
tween metabolic syndrome and ultrasound-detected mark-
ers of carotid atherosclerosis in community-dwelling
subjects in Hong Kong and tried to explore reasons for the
seemingly paradoxical coexistence of the high prevalence of
metabolic syndrome and low prevalence of carotid stenosis
in China.
Methods
Subjects
The Hong Kong Cardiovascular Risk Factor Prevalence
Study (CRISPS) was a community-based prospective cohort
study of cardiovascular risk factors in Hong Kong Chi-
nese.16,17 The study was approved by the Institutional Re-
view Board of the University of Hong Kong/Hospital
Authority Hong Kong West Cluster, and all subjects pro-
vided written informed consent prior to participation. Sub-
jects of CRISPS-3 (2005–2008) recruited between April, 2007,
and September, 2008, were screened. Those who underwent
carotid duplex ultrasonography (CD) and had no missing
values for metabolic syndrome components as mentioned
below were enrolled in the present cross-sectional study.
Smoking habits and histories of common vascular risk fac-
tors and medications were collected. Those who had ever
smoked, no matter whether they quit or not, were regarded
as ever-smokers. Fasting blood was analyzed for FBG, TG,
HDL-C, low-density lipoprotein cholesterol (LDL-C), and
total cholesterol (TC).
Metabolic syndrome
Metabolic syndrome was defined according to the US
National Cholesterol Education Program (NCEP) criteria.10
Subjects with three or more of the following conditions were
regarded as having metabolic syndrome: (1) Abdominal
obesity (waist circumference ‡ 90 cm for Asian men or
‡ 80 cm for Asian women); (2) elevated TG levels (‡ 1.7
mmol/L); (3) low HDL-C levels (< 1.03 mmol/L in men or
< 1.29 mmol/L in women); (4) hypertension (blood pressure
‡ 130/85mmHg or known hypertension); and (5) impaired
FBG levels (‡ 5.6 mmol/L or known diabetes mellitus). Re-
ceiving specific treatment for a criterion was counted as
fulfilling the criterion.
CD protocol
CD was performed by an experienced technician using a
Terason t3000 Ultrasound System (TerasonTM, Burlington,
MA) with a 7-MHz high-resolution linear-array transducer.
Longitudinal B-mode images showing the greatest distance
between the lumen–intima interface and the media–adventitia
interface were stored for subsequent offline analysis, which
was performed by another technician unaware of the
patients’ clinical data, using semiautomatic, computerized
edge-detection and measurement software MATH (version
3.0, METRIS Co., Argenteuil, France). CIMT was measured
within a plaque-free region with a length of at least 10mm, at
the far wall of common carotid artery (CCA) proximal to the
bifurcation.18 Mean CIMT of bilateral CCAs was regarded as
the CIMT value for a single subject. A CIMT value within the
4th quartile (> 75th percentile) was considered as increased
CIMT.
Carotid plaque was detected in bilateral CCAs, bifurca-
tions, and the extracranial portion of internal carotid arteries
(ICA) and was defined as the presence of focal wall thick-
ening at least 50% greater than that of the surrounding vessel
wall, or a focal CIMT greater than 1.5mm protruding into
the lumen.18 A carotid plaque obstructing ‡ 50% of vessel
lumen of CCAs, bifurcations, or extracranial ICAs was con-
sidered as carotid stenosis.
Statistical analysis
Demographic characteristics, metabolic syndrome and its
components, and other vascular risk factors were compared
between those with or without increased CIMT, and those
with or without carotid plaques, using the Pearson chi-
squared test, trend test, or independent samples t-test.
Mean CIMT values of subjects with different numbers of
metabolic syndrome components were compared using
one-way analysis of variance (ANOVA). A linear regression
model was built to evaluate the linear relationship between
the number of metabolic syndrome components and CIMT
values. Logistic regression models were built to calculate
adjusted odds ratios (ORs) of the presence of metabolic
syndrome and the number of its components for the pres-
ence of increased CIMT and carotid plaque, respec-
tively. All statistical analyses were performed in PASW
Statistics (version 18.0, IBM SPSS Statistics, Chicago, IL).
Two-sided P values of < 0.05 were considered to be statis-
tically significant.
Results
A total of 653 community-dwelling subjects (mean age
55.1 – 10.4; 47.2% male) were recruited. An overview of de-
mographic characteristics, metabolic syndrome components,
and other vascular risk factors is shown in Table 1. Overall,
metabolic syndrome was found in 188 (28.8%) subjects
(30.8% in male and 27.0% in female), with 124 (19.0%), 196
(30.0%), 145 (22.2%), 115 (17.6%), 51 (7.8%), and 22 (3.4%)
subjects having zero to five components, respectively. Ab-
dominal obesity, elevated TG, low HDL-C, hypertension,
and impaired FBG were found in 285 (43.6%), 140 (21.4%),
266 (40.7%), 312 (47.8%), and 142 (21.7%) subjects, respec-
tively. Mean CIMT was 0.74 – 0.12mm. The 75th percentile of
CIMT values was 0.795mm, and 163 (25.0%) subjects had
increased CIMT. Carotid plaques were detected in 95 (14.5%)
subjects (62 males and 33 females), among whom only 6
(1.4%) had carotid stenosis.
Association between metabolic syndrome
and CIMT
Mean CIMT values were significantly increased with
increasing numbers of metabolic syndrome components
(P < 0.001 for one-way ANOVA; Fig. 1). Multivariate
linear regression model revealed that the number of meta-
bolic syndrome components was independently related
to CIMT values (beta = 0.015 per one component increase
with constant age, gender, ever-smoker, TC, and LDL-C;
P < 0.001).
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In univariate analysis, subjects with increased CIMT were
more likely to have metabolic syndrome (43.6% versus
23.9%, P< 0.001), and they also tended to have more meta-
bolic syndrome components (P < 0.001 for trend; Table 1 and
Fig. 2). In addition, more of those with increased CIMT had
abdominal obesity (50.9% versus 41.2%, P = 0.031), elevated
TG (28.2% versus 19.2%, P = 0.015), hypertension (70.6%
versus 40.2%, P < 0.001), and impaired FBG (38.0% versus
16.3%, P < 0.001). In multivariate logistic regression (Table 2),
the presence of metabolic syndrome was independently
FIG. 1. Mean carotid intima media thickness (CIMT) values
were significantly increased with increasing numbers of
metabolic syndrome components [P < 0.001 for one-way
analysis of variance (ANOVA)]. MetS, metabolic syndrome.
FIG. 2. Subjects with increased carotid intima media
thickness (CIMT) had more metabolic syndrome components
(P < 0.001 for trend). (black bars) Subjects with increased
CIMT; (white bars) subjects without increased CIMT. MetS,
metabolic syndrome.
Table 1. Overview of Characteristics and Univariate Analysis for Subjects with/without Increased
CIMT or Presence of Carotid Plaquea
Increased CIMT Presence of carotid plaque
Characteristics Overall (N = 653) Yes (n = 163) No (n = 490) P Yes (n = 95) No (n = 558) P
Age 55.1 (10.4) 63.3 (9.7) 52.4 (9.1) < 0.001 64.2 (10.4) 53.5 (9.5) < 0.001
Male 308 (47.2) 99 (60.7) 209 (42.7) < 0.001 62 (65.3) 246 (44.1) < 0.001
Ever-smoker 188 (28.8) 58 (35.6) 130 (26.5) 0.027 42 (44.2) 146 (26.2) < 0.001
TC (mmol/L) 4.92 (1.08) 5.09 (1.12) 4.86 (1.06) 0.017 4.97 (1.17) 4.91 (1.06) 0.607
LDL-C (mmol/L) 3.02 (0.85) 3.19 (0.90) 2.96 (0.83) 0.004 3.07 (0.94) 3.01 (0.84) 0.511
Presence of metabolic syndrome 188 (28.8) 71 (43.6) 117 (23.9) < 0.001 42 (44.2) 146 (26.2) < 0.001
Metabolic syndrome components
Abdominal obesity 285 (43.6) 83 (50.9) 202 (41.2) 0.031 44 (46.3) 241 (43.2) 0.570
Elevated TG 140 (21.4) 46 (28.2) 94 (19.2) 0.015 31 (32.6) 109 (19.5) 0.004
Low HDL-C 266 (40.7) 73 (44.8) 193 (39.4) 0.224 47 (49.5) 219 (39.2) 0.061
Hypertension 312 (47.8) 115 (70.6) 197 (40.2) < 0.001 67 (70.5) 245 (43.9) < 0.001
Impaired FBG 142 (21.7) 62 (38.0) 80 (16.3) < 0.001 39 (41.1) 103 (18.5) < 0.001
Number of metabolic syndrome components
0 124 (19.0) 11 (6.7) 113 (23.1) < 0.001b 7 (7.4) 117 (21.0) < 0.001b
1 196 (30.0) 36 (22.1) 160 (32.7) 22 (23.2) 174 (31.2)
2 145 (22.2) 45 (27.6) 100 (20.4) 24 (25.3) 121 (21.7)
3 115 (17.6) 41 (25.2) 74 (15.1) 21 (22.1) 94 (16.8)
4 51 (7.8) 20 (12.3) 31 (6.3) 10 (10.5) 41 (7.3)
5 22 (3.4) 10 (6.1) 12 (2.4) 11 (11.6) 11 (2.0)
aValues are means (standard deviation, SD) or numbers (%).
bP for trend.
CIMT, carotid intima-media thickness; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; HDL-C, high-
density lipoprotein cholesterol; FBG, impaired fasting blood glucose.
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related to increased CIMT (OR 1.17; 95% CI 1.11–2.64;
P = 0.014), after adjusting for age, male gender, ever-smoker,
TC, and LDL-C. Risks of having increased CIMT signifi-
cantly increased for those with two, three, four, or five
metabolic syndrome components, compared with those
without a metabolic syndrome component (all P val-
ues < 0.05).
Association between metabolic syndrome and
presence of carotid plaque
In univariate analysis (Table 1), subjects with carotid
plaques had a significantly higher incidence of metabolic
syndrome, compared with those had no carotid plaque
(44.2% versus 26.2%, P < 0.001). They also had more meta-
bolic syndrome components (P < 0.001 for trend; Fig. 3), and
more of them had elevated TG (32.6% versus 19.5%,
P = 0.004), hypertension (70.5% versus 43.9%, P < 0.001), and
impaired FBG (41.1% versus 18.5%, P < 0.001). However,
metabolic syndrome was not independently related to the
presence of carotid plaque (OR 1.50; 95% CI 0.92–2.46;
P = 0.108) after adjusting for age, male, and ever-smoker.
Compared with those without a metabolic syndrome com-
ponent, only those with five components (OR 7.92; 95% CI
2.30–27.33; P = 0.001) had significantly higher risk of having
carotid plaque (Table 2). The incidence of carotid stenosis
was too low (1.4%) in this study to analyze its association
with metabolic syndrome.
Discussion
In the present study, we found a high prevalence of
metabolic syndrome (28.8%) in community residents in
Hong Kong SAR, China. CIMT significantly increased with
increasing numbers of metabolic syndrome components.
Also, the presence of metabolic syndrome and the number of
its components were independent predictors for increased
CIMT. However, metabolic syndrome was not indepen-
dently related to presence of carotid plaque.
The prevalence of metabolic syndrome (30.8% in male and
27.0% in female) in our study was comparable to that in the
United States in 1999–2002, which was about 33.7% among
men and 35.4% among women, based on the NCEP defini-
tion,10 the same that used in this study except for the crite-
rion of abdominal obesity (102 and 88 cm for American males
and females, respectively).19
According to the results, metabolic syndrome was inde-
pendently associated with increased CIMT, which represents
an early stage of carotid atherosclerosis, but no significant
correlation existed between metabolic syndrome and the
presence of carotid plaque, the later stage of carotid athero-
sclerosis. This was similar to a Japanese study performed in
1540 symptomatic subjects, with metabolic syndrome inde-
pendently related to CIMT> 1.10mm but not plaque occur-
rence.20 Our results were not in accordance with the results
of a population-based study with a large sample size (6142
subjects) in eastern China, in which metabolic syndrome and
Table 2. Results for Multivariate Logistic Regression Models
Increased CIMTa Presence of carotid plaqueb
Characteristics Adjusted ORs (95% CI) P Adjusted ORs (95% CI) P
Presence of metabolic syndrome 1.72 (1.11–2.64) 0.014 1.50 (0.92–2.46) 0.108
Number of metabolic syndrome components
0 1.00 1.00
1 1.61 (0.73–3.55)c 0.240 1.40 (0.55–3.58)c 0.482
2 2.47 (1.12–5.45)c 0.026 1.61 (0.63–4.12)c 0.324
3 3.02 (1.35–6.78)c 0.007 1.72 (0.66–4.50)c 0.267
4 2.88 (1.12–7.41)c 0.028 1.58 (0.52–4.81)c 0.420
5 3.52 (1.05–11.76)c 0.041 7.92 (2.30–27.33)c 0.001
aAdjusting for age, male gender, ever-smoker, TC, and LDL-C.
bAdjusting for age, male gender and ever-smoker.
cCompared with those with no metabolic syndrome components.
CIMT, carotid intima-media thickness; OR, odds ratio; CI, confidence interval; TC, total cholesterol; LDL-C, low-density lipoprotein
cholesterol.
FIG. 3. Subjects with carotid plaques had more metabolic
syndrome components in univariate analysis (P < 0.001 for
trend). (black bars) Subjects with carotid plaque; (white
bars) subjects without carotid plaque. MetS, metabolic
syndrome.
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number of its components were reported to be associated
with increased CIMT and the presence of carotid plaque in
univariate analysis.21 However, those authors did not pro-
vide results of multivariate analysis on these associations. It
was possible that the results would be different after ad-
justing for confounding factors.
The incidence of carotid stenosis was too low (1.4%) in this
study for the analysis of its association with metabolic syn-
drome. A previous study performed among acute ischemic
stroke or transient ischemic attack patients admitted to the
UCLA Medical Center found that metabolic syndrome was
independently related to carotid stenosis in Caucasians (OR
1.98; 95% CI 1.13–3.45), but not in subjects with other ethnic
origins, after adjusting for covariates.14 Another study found
metabolic syndrome to be more associated with intracranial
arterial stenosis than carotid stenosis in a Korean popula-
tion.22 Therefore, by combining the results of our study and
previous studies on the association between metabolic syn-
drome and carotid stenosis, we determined that in popula-
tions with Asian origins, although metabolic syndrome
might affect the early stage of atherogenesis of carotid ar-
teries, later and advanced stages of carotid atherosclerosis
(mainly represented as carotid plaque and carotid stenosis)
are more probably due to other factors. This may partly ex-
plain the seemingly paradoxical coexistence of the high
prevalence of metabolic syndrome and low prevalence of
carotid stenosis in China.
The strength of our study was that we evaluated the as-
sociation between metabolic syndrome and different stages
of carotid atherosclerosis in community-dwelling subjects in
China, which to some extent further explained the racial
difference in the distribution of cervicocerebral arterial ath-
erosclerosis between Caucasians and Asians. However, the
small number of subjects with carotid stenosis made it im-
possible for analysis of its association with metabolic syn-
drome, which was a limitation of our study. Also, the
numbers of male and female subjects with carotid plaques
were not large enough for multivariate analysis of gender-
specific associations between metabolic syndrome and ca-
rotid atherosclerosis.
In conclusion, our study indicated that metabolic syn-
drome might be independently associated with early-stage
carotid atherosclerosis but not later and advanced stages of
carotid atherosclerosis in community residents in China.
Combined with results of previous studies, we also partly
explained the seemingly paradoxical coexistence of the high
prevalence of metabolic syndrome and low prevalence of
carotid stenosis in China.
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